Analysts Set Schrodinger, Inc. (NASDAQ:SDGR) Target Price at $21.75

Shares of Schrodinger, Inc. (NASDAQ:SDGRGet Free Report) have been given a consensus recommendation of “Hold” by the nine research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $21.75.

A number of analysts have recently commented on the stock. Wall Street Zen upgraded shares of Schrodinger from a “sell” rating to a “hold” rating in a report on Saturday, January 31st. KeyCorp decreased their price target on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, January 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of Schrodinger in a research report on Friday, January 9th. TD Cowen reissued a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. Finally, UBS Group initiated coverage on shares of Schrodinger in a report on Wednesday, January 7th. They issued a “neutral” rating and a $18.00 price objective on the stock.

Check Out Our Latest Analysis on SDGR

Insider Activity at Schrodinger

In other news, CEO Ramy Farid sold 3,661 shares of the business’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $12.91, for a total value of $47,263.51. Following the sale, the chief executive officer directly owned 330,824 shares of the company’s stock, valued at $4,270,937.84. The trade was a 1.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Over the last quarter, insiders sold 15,340 shares of company stock valued at $200,605. Insiders own 21.00% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in SDGR. Invesco Ltd. boosted its holdings in Schrodinger by 5.7% in the fourth quarter. Invesco Ltd. now owns 190,763 shares of the company’s stock worth $3,411,000 after acquiring an additional 10,307 shares in the last quarter. Susquehanna Portfolio Strategies LLC increased its holdings in shares of Schrodinger by 459.2% during the fourth quarter. Susquehanna Portfolio Strategies LLC now owns 158,162 shares of the company’s stock valued at $2,828,000 after acquiring an additional 129,877 shares in the last quarter. Tudor Investment Corp ET AL raised its position in shares of Schrodinger by 30.5% in the 4th quarter. Tudor Investment Corp ET AL now owns 438,925 shares of the company’s stock worth $7,848,000 after purchasing an additional 102,546 shares during the last quarter. Perceptive Advisors LLC purchased a new position in shares of Schrodinger in the 4th quarter worth about $3,619,000. Finally, Man Group plc boosted its stake in Schrodinger by 170.5% in the 4th quarter. Man Group plc now owns 441,363 shares of the company’s stock worth $7,892,000 after purchasing an additional 278,189 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Schrodinger Stock Down 2.2%

NASDAQ SDGR opened at $12.74 on Tuesday. Schrodinger has a twelve month low of $11.11 and a twelve month high of $27.63. The firm has a market capitalization of $938.56 million, a PE ratio of -8.97 and a beta of 1.57. The stock’s 50 day moving average is $14.77 and its 200 day moving average is $17.58.

Schrodinger (NASDAQ:SDGRGet Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.57. The company had revenue of $87.24 million for the quarter, compared to analysts’ expectations of $83.66 million. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The firm’s revenue for the quarter was up 4.7% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.24) earnings per share. On average, research analysts anticipate that Schrodinger will post -2.37 earnings per share for the current year.

More Schrodinger News

Here are the key news stories impacting Schrodinger this week:

  • Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
  • Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
  • Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
  • Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
  • Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
  • Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings

About Schrodinger

(Get Free Report)

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.

Further Reading

Analyst Recommendations for Schrodinger (NASDAQ:SDGR)

Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.